Search

Search Constraints

You searched for: Author/Creator Klinedinst, Brandon S.

Search Results

2. CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors. Issue 1 (24th August 2020)

5. P1‐484: DIABETES IN PRECLINICAL AD DOWNREGULATES ANXIETY AND RELATED AFFECT TASK FMRI ACTIVITY IN MIDLIFE, THEN POTENTIATES EMOTIONAL DYSFUNCTION IN LATE LIFE. (1st July 2019)

6. P2‐257: BIOTINIDASE AS A NOVEL BIOMARKER OF NEURAL CHANGES AND AD CSF BIOMARKERS ACROSS THE ALZHEIMER'S DISEASE SPECTRUM. (1st July 2019)

7. P2‐441: MITOCHONDRIAL BIOENERGETICS AND ALZHEIMER'S DISEASE: PYRUVATE KINASE AND ASSOCIATIONS WITH NEURAL AND COGNITIVE OUTCOMES. (1st July 2019)

8. P3‐233: ASSOCIATIONS OF CSF SUPEROXIDE DISMUTASE 1 WITH COGNITIVE, NEURAL, AND CSF BIOMARKERS ACROSS THE ALZHEIMER'S DISEASE SPECTRUM. (1st July 2019)

9. P3‐260: FASTING GLUCOSE AND WHITE MATTER INTEGRITY: BENEFICIAL FOLLOWED BY DETRIMENTAL ASSOCIATIONS OVER TIME IN PRECLINICAL AD AND ALONG THE AD SPECTRUM. (1st July 2019)

10. P3‐261: HYPERGLYCEMIA AND NEURAL NETWORK FUNCTIONAL CONNECTIVITY: PEAKS AND THEN TROUGHS IN MID‐ TO LATE LIFE FOR PRECLINICAL AD AND ACROSS THE AD SPECTRUM. (1st July 2019)